Literature DB >> 2842944

Mutational dissection of the HSV-1 immediate-early protein Vmw175 involved in transcriptional transactivation and repression.

T Paterson1, R D Everett.   

Abstract

Vmw175 is one of five immediate-early (IE) proteins encoded by herpes simplex virus type-1 (HSV-1). It is required for the transcription of later classes of genes and for the accompanying repression of IE expression. Vmw175 has been shown to be a transactivator of transcription and also to autoregulate its own synthesis. We have made a large number of small, in-frame, insertion and deletion mutants of a plasmid-borne copy of the gene encoding Vmw175. Study of the activity of the resultant mutant polypeptides in transient transfection assays has defined the regions of the protein important for the repression of its own promoter, and for the transactivation of an HSV early promoter in synergy with another HSV IE protein, Vmw110. Large stretches of the protein are relatively unimportant for either function, while the regions most sensitive to disruption correlate to sequences conserved between Vmw175 and VZV 140K, the corresponding transactivating protein of Varicella-Zoster virus. The region from amino acids 275 to 490 is particularly important for both repression and transactivation, whereas that from around 840 to 1100 seems to be more important for transactivation than repression. The nuclear localization signal has been mapped to within residues 682-774.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842944     DOI: 10.1016/0042-6822(88)90160-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  68 in total

1.  Identification of a motif in the C terminus of herpes simplex virus regulatory protein ICP4 that contributes to activation of transcription.

Authors:  James W Bruce; Kent W Wilcox
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Temperature-dependent conformational changes in herpes simplex virus ICP4 that affect transcription activation.

Authors:  Peter Compel; Neal A DeLuca
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  The regions important for the activator and repressor functions of herpes simplex virus type 1 alpha protein ICP27 map to the C-terminal half of the molecule.

Authors:  M A Hardwicke; P J Vaughan; R E Sekulovich; R O'Conner; R M Sandri-Goldin
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA.

Authors:  B Grondin; N DeLuca
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  The N terminus and C terminus of herpes simplex virus 1 ICP4 cooperate to activate viral gene expression.

Authors:  Lauren M Wagner; Jonathan T Lester; Frances L Sivrich; Neal A DeLuca
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

6.  Visualization of parental HSV-1 genomes and replication compartments in association with ND10 in live infected cells.

Authors:  George Sourvinos; Roger D Everett
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

7.  Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4.

Authors:  B Gu; N DeLuca
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Mutational analysis of varicella-zoster virus major immediate-early protein IE62.

Authors:  L Baudoux; P Defechereux; S Schoonbroodt; M P Merville; B Rentier; J Piette
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

9.  The conserved DNA-binding domains encoded by the herpes simplex virus type 1 ICP4, pseudorabies virus IE180, and varicella-zoster virus ORF62 genes recognize similar sites in the corresponding promoters.

Authors:  C L Wu; K W Wilcox
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Herpes simplex virus transactivator ICP4 operationally substitutes for the cellular transcription factor Sp1 for efficient expression of the viral thymidine kinase gene.

Authors:  A N Imbalzano; D M Coen; N A DeLuca
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.